Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Consolidated Statements Of Cash Flows [Abstract]
Net income	$ 1,243	$ 1,048
Adjustments to reconcile net loss to net cash from operating activities:
Provision for loan and lease losses	230	200
Depreciation	159	157
Amortization, net	(54)	36
Net loss on sales of securities		12
Originations of loans held for sale	(16,137)	(40,032)
Proceeds from sale of loans held for sale	14,657	44,054
Net gains on sales of loans	(97)	(357)
Gain on sale of foreclosed assets	(4)
Earnings on bank owned life insurance	(99)	(98)
Stock-based compensation expense	92	102
Change in deferred income taxes	(29)
Net change in:
Accrued interest receivable and other assets	1,501	665
Accrued interest payable and other liabilities	212	(171)
Net cash from operating activities	1,674	5,616
Cash flows from investing activities
Net increase in interest-bearing deposits in other financial institutions	(100)
Available-for-sale securities:
Maturities, prepayments and calls	206	3,403
Purchases		(4,573)
Loan and lease originations and payments, net	(32,130)	(31,440)
Proceeds from the sale of loans	1,124	4,099
Additions to premises and equipment	(44)	(38)
Proceeds from the sale of foreclosed assets	200
Net cash used by investing activities	(30,744)	(28,549)
Cash flows from financing activities
Net change in deposits	55,376	15,479
Proceeds from FHLB advances	37,600	2,500
Repayments on FHLB advances	(36,600)	(2,500)
Net change in advances by borrowers for taxes and insurance	(307)	(90)
Cash dividends paid on Series B preferred stock	(562)	(562)
Purchase of treasury shares	(30)
Net cash from financing activities	55,477	14,827
Net change in cash and cash equivalents	26,407	(8,106)
Beginning cash and cash equivalents	25,895	28,207
Ending cash and cash equivalents	52,302	20,101
Supplemental cash flow information:
Interest paid	2,205	1,926
Supplemental noncash disclosures:
Loans issued to finance the sale of repossessed assets	1,440
Loans transferred from held for sale to portfolio		834
Loans transferred from portfolio to held for sale		1,561
Dividends payable on Series B preferred stock	$ 187	$ 187